The ability of cellular assays to predict the necessity for cordocenteses in pregnancies at risk of haemolytic disease of the newborn [1]

Vox Sanguinis

Volumn 80, Issue 4, 2001, Pages 234-

  Zupanska B ^a  

^a INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AMNIOCENTESIS; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; CELL ASSAY; CHEMOLUMINESCENCE; CORDOCENTESIS; HUMAN; LETTER; MATERNAL SERUM; NEWBORN HEMOLYTIC DISEASE; PREGNANCY; PRIORITY JOURNAL;

ADULT; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; CHEMILUMINESCENT MEASUREMENTS; CORDOCENTESIS; ERYTHROBLASTOSIS, FETAL; FEMALE; HUMANS; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; PREDICTIVE VALUE OF TESTS; PREGNANCY;

EID: 0035353370     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1423-0410.2001.00033.x     Document Type: Letter

References (5)

1. Hadley AG, Kumpel BM, Leader KA, Poole GD, Fraser ID: Correlation of serological, quantitative and cell-mediated functional assays of maternal alloantibodies with the severity of haemolytic disease of the newborn. Br J Haematol 1991; 77:221-228
2. Engelfriet CP, Ouwehand WH: ADCC and other cellular bioassays for the clinical significance of red cell alloantibodies. Baillieres Clin Haematol 1990; 3:321-337
3. Engelfriet CP, Reesink HW: Laboratory procedures for the prediction of the severity of haemolytic disease of the newborn. Vox Sang 1995; 69:61-69
4. Neppert J, Witzleben-Schurholz E v, Upaska B, Barz L, Greve O, Eichler H, Kerowgan M, Wichman MG: High incidence of maternal HLA A, A and C antibodies with a mild course of haemolytic disease of the newborn. Eur J Haematol 1999; 63:120-125
5. Hadley AG, Wilkes A, Goodrick J, Penman D, Soothill P, Lucas G: The ability of the chemiluminescence test to predict clinical outcome and the necessity for amniocenteses in pregnancies at risk of haemolytic disease of the newborn. Br J Obstet Gynaecol 1998; 105:231-234